SVP, Chief Financial Officer
Orexigen Therapeutics, Inc.
United States of America
Jason Keyes is an accomplished executive with 15 years of experience in corporate finance and strategy within the biotechnology industry. Upon joining Orexigen in 2013, Jason has held various financial senior leadership positions, including Vice President of Finance, where he led the Company’s financial planning and partnership finance functions and served as a key financial advisor to executive management in setting corporate business and financial strategy. Prior to joining Orexigen, Jason was Senior Director of Finance at Amylin Pharmaceuticals, Inc., which was acquired by Bristol-Myers Squibb in 2012. Previously he worked in finance and corporate strategy at Amgen, Inc. and at Baxter Healthcare Corporation. He is also a licensed professional engineer and has six years of experience in the environmental engineering industry. Jason holds Bachelor of Science and Master of Science degrees in Civil Engineering from Stanford University and a Master of Business Administration degree from the Anderson School at the University of California, Los Angeles.
Environmental engineering, Civil Engineering